The utility of histopathological features predicting microsatellite high (MSI-H) colorectal cancer in a limited setting

被引:0
|
作者
Horpaopan, Sukanya [1 ]
Somran, Julintorn [2 ]
机构
[1] Naresuan Univ, Dept Anat, Fac Med Sci, Phitsanulok 65000, Thailand
[2] Naresuan Univ, Dept Pathol, Fac Med, Phitsanulok 65000, Thailand
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2020年 / 13卷 / 03期
关键词
Colorectal cancer (CRC); microsatellite instability (MSI); histopathology; mismatch repair (MMR) genes; LYNCH-SYNDROME; MOLECULAR CHARACTERISTICS; COLON-CANCER; INSTABILITY; CRITERIA; TUMORS; BAT26;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide. Approximately 15% of CRCs have microsatellite instability (MSI), which is caused by a dysfunction of the DNA mismatch repair (MMR) genes. The histopathological features have been applied to predict high frequency MSI (MSI-H) in CRCs, and we investigated this association with MSI-H and the histopathological features. Materials and methods: Fifty-four tumors were evaluated based on nine histopathological features associated with MSI-H. DNA was extracted and prepared from the FFPE of tumors and normal colon tissue. Five microsatellite markers (BAT25, BAT26, D2S123, D5S346, and D17S250) were screened. Results: Of the 54 cases, 38 (70.4%) were between 50-60 years old, and 16 (29.6%) were younger than 50 years. Tumors mainly presented in the left-side colon (40 cases, 74.1%). MSI-high (MSI-H) was found in 7 cases, MSI-low (MSI-L) was found in 7 cases, and the rest were microsatellite stable (MSS). The majority of CRC with MSI-H showed a Crohn-like lymphocytic reaction, mucinous features, tumor grade 2, and tumor-infiltrating lymphocytes. Only the mucinous component was significantly associated with the MSI-H (P < 0.05). Conclusion: The initial prevalence of MSI-CRCs in our study (via 5 microsatellite markers) was similar to previous studies. Some histopathological features helped to guide the MSI testing. Even though only the mucinous features were related to the MSI-H status, none of MSI-H CRCs lacked any of the of 9 selected histopathological features. Our study was limited by selected age groups and a small sample size. Further studies with more samples including all age groups should be performed to demonstrate the usefulness of the histopathological features in predicting the MSI in CRC.
引用
收藏
页码:1878 / 1887
页数:10
相关论文
共 50 条
  • [31] High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
    Zoran Gatalica
    Semir Vranic
    Joanne Xiu
    Jeffrey Swensen
    Sandeep Reddy
    Familial Cancer, 2016, 15 : 405 - 412
  • [32] Mutations in the WTX - gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers
    Scheel, Silvio K.
    Porzner, Marc
    Pfeiffer, Sabine
    Ormanns, Steffen
    Kirchner, Thomas
    Jung, Andreas
    BMC CANCER, 2010, 10
  • [33] High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
    Gatalica, Zoran
    Vranic, Semir
    Xiu, Joanne
    Swensen, Jeffrey
    Reddy, Sandeep
    FAMILIAL CANCER, 2016, 15 (03) : 405 - 412
  • [34] Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164
    Le, D.
    Kavan, P.
    Kim, T.
    Burge, M.
    Van Cutsem, E.
    Hara, H.
    Boland, P.
    Van Laethem, J.
    Geva, R.
    Taniguchi, H.
    Crocenzi, T.
    Sharma, M.
    Atreya, C.
    Diaz, L.
    Liang, L.
    Marinello, P.
    Dai, T.
    O'Neill, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Clinicopathological Features of Colorectal Carcinoma in Ukrainian Patients with MSI-H and MSS Status
    Shapochka, D.
    Vykhrieva, M.
    Selezniov, O.
    Turkina, A.
    Shapochka, T.
    Sulaieva, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S30 - S30
  • [36] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [37] Nivolumab with ipilimumab for MSI-H colorectal cancer with liver metastases.
    Michalaki, Vasiliki
    Theodosopoulos, Theodosios
    Frangoulidis, George
    Dafnios, Nikolaos
    Papakonstantinou, Ioannis
    Vezakis, Antonios
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15556 - E15556
  • [38] The clinical courses of solid tumors with microsatellite instability-high (MSI-H)
    Inagaki, Yuichiro
    Ohara, Fumiya
    Yokota, Hirofumi
    Takeuchi, Yuki
    Sawa, Hitomi
    Miyao, Kotaro
    Takashi, Seki
    Arima, Junko
    Yoneyama, Eiji
    Sawa, Masashi
    ANNALS OF ONCOLOGY, 2021, 32 : S344 - S344
  • [39] Association of CDX2 expression with clinical, pathologic, and molecular features in MSI-H colorectal cancer
    Gonzalez, Cyndi
    Neyaz, Azfar
    Layding, Caroline Jane
    Ferrell, Morgan
    Giza, Richard
    Cheng, Svea
    Syed, Masood Pasha
    Magge, Tara
    Saeed, Anwaar
    Tatsuoka, Curtis
    Singhi, Aatur D.
    Sahin, Ibrahim Halil Halil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Immunotherapy for MSI-H colorectal cancer with isolated peritoneal metastases.
    Metzger, Daniel Aryeh
    Watman, Olivia
    Li, Ying
    Pigazzi, Alessio
    Siolas, Despina
    Jafari, Mehraneh D.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 187 - 187